Description
BRIN-BG7 cell line is a hybrid cell line formed by the electrofusion of a primary culture of NEDH rat pancreatic islets with RINm5F. BRIN-BG7 has been shown to be tumourigenic when transplanted into a SCID mouse host. BRIN-BG7 has been mycoplasma eradicated at Glow Biologics and the stocks available for supply have undergone a further 10 passages without detection of mycoplasma. The cell line has applications in the study of pancreatic beta cell function.
Adherent Suspension
Adherent
Suggested Medium
RPMI-1640 + 2mM Glutamine + 10% FCS
Quality Control
BRIN-BG7 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
BRIN-BG7 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
BRIN-BG7 Cell Line is for research use only
